# Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

> **NCT05796258** · — · COMPLETED · sponsor: **Regina Elena Cancer Institute** · enrollment: 100 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DIAGNOSTIC_TEST:** NTRK fusion assessment

## Key facts

- **NCT ID:** NCT05796258
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-26
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05796258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05796258, "Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05796258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*